申请人:HOFFMANN LA ROCHE
                            
                            
                                公开号:WO2013092467A1
                            
                            
                                公开(公告)日:2013-06-27
                            
                            Disclosed are compounds of Formula (I), useful for treatment of autoimmune and inflammatory diseases associated with IL-2 inhibition via modulation of calcium release-activated calcium (CRAC) channels. Also disclosed are methods of making and using the compounds for treatment of diseases associated with CRAC channels.